Beyond the Numbers: Five Key Questions Analysts Posed to Danaher After Mixed Q4 Results
While Danaher met Q4 revenue targets on bioprocessing and diagnostics strength, analyst questions during the earnings call revealed deeper concerns about research funding softness and the sustainability of growth drivers in a challenging macro environment.